Terms: = Bone cancer AND RAP1GDS1, P52306, 5910, MGC118861, MGC118859, GDS1, ENSG00000138698 AND Treatment
2 results:
1. A multi-center, single-arm, phase II study of anlotinib plus paclitaxel and cisplatin as the first-line therapy of recurrent/advanced esophageal squamous cell carcinoma.
Li N; Wu T; Hong YG; Guo YZ; Cheng YF; Ma YJ; Bie LY; Cui DH; Gao XH; Tan BX; Li BS; Luo SX; Wang JS
BMC Med; 2022 Dec; 20(1):472. PubMed ID: 36482345
[TBL] [Abstract] [Full Text] [Related]
2. [Clinical characteristics and treatment analysis of primary breast lymphoma: 49 cases report].
Qiu LH; Wang HQ; Qian ZZ; Li W; Hou Y; Meng XR; Cui XZ; Hao XS
Zhonghua Wai Ke Za Zhi; 2010 May; 48(10):743-6. PubMed ID: 20646489
[TBL] [Abstract] [Full Text] [Related]
